Published in Artery on January 01, 1980
Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci U S A (1988) 1.38
Morphology and cell kinetics of fatty streak lesion formation in the hypercholesterolemic rabbit. Am J Pathol (1986) 1.10
Evidence for cell death in the vascular endothelium in vivo and in vitro. Am J Pathol (1983) 1.00
LDL enhances monocyte adhesion to endothelial cells in vitro. Am J Pathol (1986) 0.89
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis (1986) 5.23
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1995) 3.54
Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis (1999) 3.21
Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation (2000) 3.17
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest (1991) 2.76
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet (1990) 2.55
Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest (1998) 2.27
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest (1985) 2.16
T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb (1992) 2.09
Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol (1996) 1.88
Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest (1992) 1.83
Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest (1998) 1.80
Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol (1986) 1.70
In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation (2001) 1.69
Nuclear factor kappa-B and the heart. J Am Coll Cardiol (2001) 1.68
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation (2001) 1.63
Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res (1992) 1.56
Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Am J Med (1993) 1.50
Correlations between clinical variables and gene-expression profiles in carotid plaque instability. Eur J Vasc Endovasc Surg (2011) 1.50
Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb (1991) 1.46
Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet (1988) 1.46
Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol (1996) 1.41
Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. Am J Pathol (1991) 1.39
Reduced frequency of memory CD8+ T lymphocytes in cerebrospinal fluid and blood of patients with multiple sclerosis. Autoimmunity (1995) 1.39
LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 1.39
Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci U S A (1988) 1.38
Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis (1999) 1.38
Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest (1991) 1.35
Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2000) 1.30
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A (1999) 1.28
Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis (1998) 1.24
Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab Invest (1989) 1.21
Activation of inducible nitric oxide synthase/nitric oxide by curli fibers leads to a fall in blood pressure during systemic Escherichia coli infection in mice. J Infect Dis (2001) 1.19
Pulse-chase studies of the synthesis and intracellular transport of apolipoprotein B-100 in Hep G2 cells. J Biol Chem (1986) 1.19
Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand J Immunol (2004) 1.19
Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis (1996) 1.18
Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim Biophys Acta (1990) 1.18
Smooth muscle cells express Ia antigens during arterial response to injury. Lab Invest (1988) 1.18
Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand J Immunol (1999) 1.17
Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J Clin Invest (1996) 1.16
Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res (1991) 1.14
Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells. Proc Natl Acad Sci U S A (1984) 1.14
Apolipoprotein B: structure, biosynthesis and role in the lipoprotein assembly process. Atherosclerosis (1987) 1.13
Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis (1990) 1.13
Immunohistochemical localization of lipoprotein lipase in human adipose tissue. Atherosclerosis (1984) 1.12
Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med (2008) 1.12
Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb Haemost (2011) 1.10
Evidence for antigen-driven T-cell response in unstable angina. Circulation (2000) 1.09
Endothelial integrity and viability in the aorta of the normal rabbit and rat as evaluated with dye exclusion tests and interference contrast microscopy. Atherosclerosis (1972) 1.08
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Studies on the assembly of apo B-100-containing lipoproteins in HepG2 cells. J Biol Chem (1988) 1.07
Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb (1994) 1.07
Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol Microbiol Immunol Scand A (1984) 1.07
The assembly and secretion of apoB 100 containing lipoproteins in Hep G2 cells. Evidence for different sites for protein synthesis and lipoprotein assembly. J Biol Chem (1990) 1.07
Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res (1998) 1.06
Immune mechanisms in atherosclerosis. Coron Artery Dis (1994) 1.06
Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels. J Intern Med (1990) 1.05
Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J Lipid Res (1990) 1.05
Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res (1996) 1.04
Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol (1989) 1.04
Identification of Apo B-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arteriosclerosis (1988) 1.04
Arterial repair and atherosclerosis after mechanical injury. I. Permeability and light microscopic characteristics of endothelium in non-atherosclerotic and atherosclerotic lesions. Atherosclerosis (1972) 1.02
Ultrastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic rabbits. Exp Mol Pathol (1980) 1.02
Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest (1996) 1.02
Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res (1999) 1.01
The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur J Immunol (1999) 1.01
Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am J Pathol (2001) 1.00
Psychosocial stress causes endothelial injury in cynomolgus monkeys via beta1-adrenoceptor activation. Atherosclerosis (1998) 1.00
Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. Am J Pathol (1985) 1.00
Evidence for cell death in the vascular endothelium in vivo and in vitro. Am J Pathol (1983) 1.00
Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp Cell Res (1988) 0.99
Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis (1981) 0.99
Molecular basis of the association of arterial proteoglycans with low density lipoproteins: its effect on the structure of the lipoprotein particle. Eur Heart J (1990) 0.99
Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol (1993) 0.98
Arterial repair and atherosclerosis after mechanical injury. 2. Tissue response after induction of a total local necrosis deep longitudinal injury. Atherosclerosis (1972) 0.97
Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler Thromb Vasc Biol (1999) 0.96
Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. J Clin Invest (1989) 0.96
Fc-dependent binding of monocytes to areas with endothelial injury in the rabbit aorta. Exp Mol Pathol (1981) 0.96
Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol (1995) 0.96
MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin. Immunology (1990) 0.95
Isolation and partial characterization of a polypeptide belonging to apolipoprotein B from low-density lipoproteins of human plasma. Biochemistry (1980) 0.95
Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem (1993) 0.95
Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. Arterioscler Thromb Vasc Biol (1999) 0.95
The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol (2005) 0.95
Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg (2000) 0.95
Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. J Lipid Res (1987) 0.94
Molecular cloning of human apolipoprotein B cDNA. Nucleic Acids Res (1985) 0.93
Isolation and characterization of endothelial cells from the epididymal fat pad of the rat. J Lipid Res (1983) 0.93
Fluorometric determination of cholesterol and cholesteryl ester in tissue on the nanogram level. Anal Biochem (1971) 0.93
Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp Cell Res (1994) 0.92
Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins. Diabetes (1999) 0.92